|
Genetic thrombophilia markers in patients and controls |
||||
| Thrombophilia marker |
Patients (n = 32) Number positive (%) |
Controls (n = 100) Number positive (%) |
RR (95% CI) |
P value |
|
|
||||
| FVL Het |
4 (12.5) |
0 |
4.0 (1.8–4.5) |
0.001 |
| PT G20210A |
0 |
0 |
- |
- |
| EPCR Hets |
1 (3.13) |
1 (1) |
2.0 (0.3–3.8) |
0.392 |
| MTHFR homo |
1 (3.13) |
1 (1) |
2.0 (0.3–3.8) |
0.392 |
| MTHFR hetero |
6 (18.75) |
12 (12) |
1.46 (0.6–2.7) |
0.333 |
| Fib β448 homo |
1(3.13) |
1(1) |
2.0 (0.3–3.8) |
0.392 |
| Fib β448 hetero |
5 (15.63) |
12 (12) |
1.2 (0.5–2.5) |
0.594 |
| PAI 4G/4G |
13 (40.63) |
10 (10) |
3.2 (1.8–5.1) |
0 |
| 4G/5G |
12 (37.5) |
61 (61) |
0.4 (0.2–0.8) |
0.020 |
| 5G/5G |
5 (15.63) |
29 (29) |
0.5 (0.2–1.1) |
0.132 |
| PC Def |
1 (3.13) |
0 |
2.8 (0.5–4.1) |
0.223 |
| P S Def |
7 (21.88) |
0 |
4.6 (2.6–5.6) |
0 |
| AT III Def |
0 |
0 |
- |
- |
Vora et al. Thrombosis Journal 2007 5:9 doi:10.1186/1477-9560-5-9 |
||||